However, as we already reported [20], among 16 Ph + lymphoid leukemia cell lines we had tested, 10 cell lines were sensitive to olaparib, a poly (ADP-Ribose) polymerase- 1 (PARP- 1) inhibitor, suggesting that their HR pathway is somehow disrupted. Here, PARP1 is linked to lymphoid leukemia.